Functional neurology
What studies of functional neurology found
At a glance, by condition
ME/CFS: C Might help, very uncertain
Based on the strongest evidence, studies with no comparison group (very low certainty): 3 findings, all C.
3 outcomes rated · see each below
How we got this
Each condition’s headline comes from its graded findings (one for each outcome and kind of study) rated with the highest certainty: the grade most of them share; a tie goes to the finding with the most people, then the most studies, then the outcome’s name. It sums up the grades below, and conditions are never combined.
What this means: Functional neurology might help some people with ME/CFS, but research can’t show it yet. If you’re thinking about it, talk it through with a doctor who knows ME/CFS or long COVID.
Ask about this treatment
The grades, in plain words
Each outcome gets a direction, a certainty and a letter read from the two. Certainty is judged with GRADE, the method Cochrane and WHO use.
- AHelpsImprovement, high certaintyProbably helpsImprovement, moderate certainty
- BMay helpImprovement, low certainty
- Functional neurology · ME/CFS is hereCMight help, very uncertainImprovement, very low certaintyMixed resultsStudies disagree
- DLittle or no differenceStudies found little or no difference
- FHarmsIt made things worse
By symptom and daily life
ME/CFS
Daily life and health overall
Daily functioning1 study · 1 (few people) person tried functional neurology Improvement C
Why this grade: Improvement, very low certainty, from studies without a control group: no control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design); few people (1 in all); not all results were tested against chance.
Studies with no comparison group1 in the study · In 10 treatment days · slow systemic approach (few people)
Daily functioning improved.
The evidence is very uncertain about the effect of functional neurology on daily functioning in ME/CFS. Improvement · very low certainty C
- No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
- Few people (1 in all)
- Not all results were tested against chance
See the 1 study
-
- People in the study
- 1 in the study
- Dose
- slow systemic approach
- Outcome
- able to eat regular
- Effect
- better (not tested)
- Risk of bias
- case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
Overall symptoms1 study · 1 (few people) person tried functional neurology Improvement C
Why this grade: Improvement, very low certainty, from studies without a control group: no control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design); few people (1 in all); not all results were tested against chance.
Studies with no comparison group1 in the study · In 10 treatment days · slow systemic approach (few people)
Overall symptoms improved.
The evidence is very uncertain about the effect of functional neurology on overall symptoms in ME/CFS. Improvement · very low certainty C
- No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
- Few people (1 in all)
- Not all results were tested against chance
See the 1 study
-
- People in the study
- 1 in the study
- Dose
- slow systemic approach
- Outcome
- IBS and all other symptoms
- Effect
- better (not tested)
- Risk of bias
- case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
Quality of life1 study · 1 (few people) person tried functional neurology Improvement C
Why this grade: Improvement, very low certainty, from studies without a control group: no control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design); few people (1 in all); not all results were tested against chance.
Studies with no comparison group1 in the study · In 10 treatment days · slow systemic approach (few people)
Quality of life improved.
The evidence is very uncertain about the effect of functional neurology on quality of life in ME/CFS. Improvement · very low certainty C
- No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
- Few people (1 in all)
- Not all results were tested against chance
See the 1 study
-
- People in the study
- 1 in the study
- Dose
- slow systemic approach
- Outcome
- normal life with his friends
- Effect
- better (not tested)
- Risk of bias
- case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
Side effects
No study of this treatment alone reported side effects we could read.
All papers
- Irritable Bowel Disease Complicated by Food Intolerances, Malabsorption, Dysphagia, Weight Loss, Brain Fogginess, Light-Headedness, and Chronic Fatigue: A Functional Neurology and Neuro-Visceral Applications� Approach.2016 · case report · 1 in the study
Summary
This conference abstract reports one 30-year-old male who presented to the authors' clinic on 02/24/2016 with digestive issues, mental issues, throat issues, headaches, light-headedness, stomachaches, difficulty breathing, and chronic fatigue; he reported a diagnosis of Chronic Fatigue Syndrome. He had been put on Clonazepam, Amitriptyline, Famotidine, Dicyclomine, HCL, Dexilant and several others. A slow systemic Functional Neurology and Organ Remapping approach was implemented, including visual, auditory, vestibular, sensory and motor applications, brain based activities, cerebellar activation, complex therapeutic activities, home instructions and dietary changes. There was no comparison group. The abstract reports that his IBS was contained and that in 10 treatment days his IBS and all other symptoms were resolved; he enjoys a normal life with his friends, able to eat regular, and has resumed work as a programmer. It also reports that he reported an overall feeling of ill-being and increase in his symptoms, and further debilitation (1 patient); the text does not state a cause. No side-effect counts or withdrawals are reported.